ElShaer Amr, Ghatora Baljit, Mustafa Shelan, Alany Raid G
Drug Discovery, Delivery & Patient Care (DDDPC), Kingston University London, Kingston upon Thames, KT1 2EE, UK.
Ther Deliv. 2014 Oct;5(10):1085-100. doi: 10.4155/tde.14.73.
Although conventional eye drops comprise over 90% of the marketed ocular dosage forms, they do have limitations, such as poor ocular drug bioavailability and systemic side effects; contact lenses are amongst the new delivery systems and devices that could overcome some of these problems. The most common approach to load drug molecules into contact lenses includes soaking in a drug solution. This approach had some success, but failed to achieve controlled/sustained drug release to the eye. On [corrected] the other hand, nanoreservoir systems comprising nanoparticles, cyclodextrins, liposomes or surfactant aggregates being incorporated into the contact lenses could offer a plausible solution. This review highlights the status quo with contact lenses as ocular drug-delivery carriers and identifies possible future directions.
尽管传统眼药水占市场上眼部剂型的90%以上,但它们确实存在局限性,如眼部药物生物利用度低和全身副作用;隐形眼镜是能够克服其中一些问题的新型给药系统和装置之一。将药物分子载入隐形眼镜最常见的方法是浸泡在药物溶液中。这种方法取得了一些成功,但未能实现对眼睛的药物控释/缓释。另一方面,将纳米颗粒、环糊精、脂质体或表面活性剂聚集体等纳米储库系统掺入隐形眼镜中可能提供一个可行的解决方案。本综述重点介绍了隐形眼镜作为眼部药物递送载体的现状,并确定了未来可能的发展方向。